On 27 November 2020, Bert Damiaans will defend his PhD thesis on
Investigating and quantifying biosecurity in Belgian cattle production
The defense will take place on Friday 27 November 2020 at 17h. Due to the current Covid-19 measures, the defense will only be accessible via live-stream. If you wish to participate in the videoconference, please register by sending an e-mail to firstname.lastname@example.org to receive a personal invitation.
Biocheck provides a unique risk-based scoring system to measure the level of biosecurity in pig, poultry and cattle farms.
Biocheck allows an easy and fast quantification of a farm’s biosecurity, which is key in animal disease prevention. Access to the system, which is marketed as a SaaS-based solution can be offered through an API.
Biocheck uses a calculation algorithm which takes into account all important risk factors, their frequency of occurrence, and interactions. It has been developed through years of scientific research and has been used and validated successfully in multiple studies pertaining to biosecurity.
Biocheck is unique in its kind, it is the only system available that provides a risk-based quantitative evaluation of biosecurity at farm-level.
Biocheck is continuously improved to stay in line with the most recent scientific insights. It has one of the largest databases, increasing continuously in size and global coverage, with biosecurity practices around the world. It has gathered international recognition as one of the most user-friendly and advanced systems of its kind.
Congratulations to Prof. Dr. Kristien van Reeth, member of PROVAXS, who participated with the award-winning presentation “Expanding anti-influenza antibody responses by heterologous prime-boost vaccination or “variations on a vaccine”” to the 3rd edition of the GSK Meets Belgian Universities Digital Event which was held on October 27, 2020.
Her presentation is a clear expample of how Cross Health research can lead to insights that are valuable for vaccine development in different species.